Home / Products / Cancer / Lung Cancer

Lung Cancer


Available treatments for Lung Cancer
You can order a treatment for Lung Cancer via TheSocialMedwork if it has not been approved and/or is not available in the patient's country. TheSocialMedwork - helping patients and doctors access the latest approved medicines and at the lowest price possible worldwide.
pill
View Product

Alecensa

(alectinib)

by: Roche
for: Lung Cancer
• EMA approved (EU)
• FDA approved (USA)
• PMDA approved (JAP)
• TGA approved (AUS)

pill
View Product

Alunbrig

(brigatinib)

by: ARIAD Pharmaceuticals
for: Lung Cancer
• FDA approved (USA)
drip
View Product

Keytruda

(pembrolizumab)

by: Merck & co
for: Head and Neck Cancer / Lung Cancer / Urothelial Carcinoma / Skin Cancer / Lymphoma / MSI-H or dMMR solid tumours
• EMA approved (EU)
• FDA approved (USA)
• TGA approved (AUS)

injection
View Product

Opdivo

(nivolumab)

by: Bristol-Myers Squibb
for: Colorectal Cancer / Head and Neck Cancer / Hodgkin Lymphoma / Kidney Cancer / Lung Cancer / Urothelial Carcinoma / Skin Cancer
• EMA approved (EU)
• FDA approved (USA)
• PMDA approved (JAP)
• TGA approved (AUS)

drip
View Product

Portrazza

(necitumumab)

by: Eli Lilly and Co.
for: Lung Cancer
• EMA approved (EU)
• FDA approved (USA)

pill
View Product

Tagrisso

(osimertinib)

by: AstraZeneca
for: Lung Cancer
• EMA approved (EU)
• FDA approved (USA)
• TGA approved (AUS)

drip
View Product

Tecentriq

(atezolizumab)

by: Genentech
for: Lung Cancer / Bladder Cancer
• FDA approved (USA)
• TGA approved (AUS)

pill
View Product

Zykadia

(ceritinib)

by: Novartis
for: Lung Cancer
• EMA approved (EU)
• FDA approved (USA)
• TGA approved (AUS)

unknown
Enquire now

We may still be able to get it for you, provided that:

• it hasn't been approved and/or isn't available in your country
• you and your treating doctor have evaluated that the medicine is suitable for you, and your doctor writes a prescription for it.


About lung cancer

Lung cancer, also known as lung carcinoma, is characterized by uncontrolled cell growth in tissues of the lung. The two main types are small-cell lung carcinoma (SCLC) and non-small-cell lung carcinoma (NSCLC) [1]. Non-small cell lung cancer (NSCLC) accounts for approximately 85 % of all lung cancers [2].

With an incidence of 1.8 million lung cancer was in 2012 the most common cancer worldwide contributing 13 % of the total number of new cases diagnosed [3].

Treatment and long-term outcomes depend on the type of lung cancer, the stage (degree of spread), and the person’s overall health. Common lung cancer treatments include surgery, chemotherapy, and radiotherapy. NSCLC is sometimes treated with surgery, whereas SCLC usually responds better to chemotherapy and radiotherapy [1].

The above products may be suitable for treating patients with lung cancer. We recommend that you discuss the suitability of possible treatment options with your doctor. For further information please contact our support team at support@thesocialmedwork.com.


Registered with the Dutch Ministry of Health as an independent intermediary, Registration number 6730 BEM



Share our website

Follow us


DISCLAIMER: The Services of TheSocialMedwork do not replace a physician-patient relationship and are not intended as medical advice. TheSocialMedwork provides patients and physicians with existing treatment options abroad and creates access to these options after the patient and physician have made a professional decision. Privacy Policy / Terms and Conditions
Our service uses cookies.